Back to Archived Journals » Research and Reports in Nuclear Medicine » Volume 1

Editorial

Authors Gayed I

Published 7 June 2011 Volume 2011:1 Pages 9—10

DOI https://doi.org/10.2147/RRNM.S18855


Isis W Gayed
Nuclear Medicine Section, Department of Diagnostic and Interventional imaging, University of Texas Health Science Center at Houston, TX, USA
The field of nuclear medicine has witnessed major advances in imaging technology and radiopharmaceuticals development in a relatively short time interval. An impressive leap has occurred between the invention of the first gamma camera by Anger in 19571 to the presently widely available hybrid technology of positron emission tomography - computed tomography (PET-CT) and single-photon emission computed tomography - computer tomography (SPECT-CT).2 The field is yet to witness the impact of the emerging PET-magnetic resonance imaging (MRI) scanners. The variability of available radiopharmaceuticals to evaluate various body functions adds to the uniqueness of this field of functional imaging.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]